TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo January 28, 2022 John Ayangoglou Chief Financial Officer Biotricity, Inc. 275 Shoreline Drive, Suite 150 Redwood City, California 94065 Re: Biotricity, Inc. Registration Statement on Form S-3 Filed January 21, 2022 File No. 333-262288 Dear Mr. Ayangoglou : This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Rajiv Radia, Esq.